Correlation Between Anika Therapeutics and Hyperfine

Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Hyperfine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Hyperfine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anika Therapeutics and Hyperfine, you can compare the effects of market volatilities on Anika Therapeutics and Hyperfine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Hyperfine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Hyperfine.

Diversification Opportunities for Anika Therapeutics and Hyperfine

0.63

Correlation Coefficient

Anika Therapeutics  Hyperfine

Poor diversification

The 3 months correlation between Anika and Hyperfine is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Hyperfine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyperfine and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Hyperfine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyperfine has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Hyperfine go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Hyperfine

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Hyperfine. But the stock apears to be less risky and, when comparing its historical volatility, Anika Therapeutics is 4.35 times less risky than Hyperfine. The stock trades about -0.05 of its potential returns per unit of risk. The Hyperfine is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  88.00  in Hyperfine on December 29, 2024 and sell it today you would lose (16.00) from holding Hyperfine or give up 18.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Anika Therapeutics  vs.  Hyperfine

Anika Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Anika Therapeutics is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Hyperfine

Risk-Adjusted Performance

Weak

Over the last 90 days Hyperfine has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively weak basic indicators, Hyperfine may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Anika Therapeutics and Hyperfine

The main advantage of trading using opposite Anika Therapeutics and Hyperfine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Hyperfine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyperfine will offset losses from the drop in Hyperfine's long position.

The idea behind Anika Therapeutics and Hyperfine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.